Company: APXIF
Filing Date: 2025-01-22
Form Type: F-4
Source: 0001213900-25-005463
Chunk: 234

Company: APx Acquisition Corp. I
Filing Date: 2025-01-22
Form: F-4
Chunk 234
---
     |               1,806 |     |       2,851 |     |                 9,206 |           |     |      13,864 |     |                 9,206 |           |     |      13,864 |     |                 9,206 |           |     | 13,864 |
| Total liabilities                           |     |               4,579 |     |      70,707 |     |               (56,146 | )         |     |      19,141 |     |               (56,146 | )         |     |      19,141 |     |               (56,146 | )         |     | 19,141 |
| Total liabilities and equity                |     |               1,733 |     |      64,953 |     |               (54,197 | )         |     |      12,493 |     |               (54,197 | )         |     |      12,493 |     |               (54,197 | )         |     | 12,493 |

____________ Notes:- (i)The historical financial information of APx has been adjusted to give effect to the differences between GAAP and IFRS as issued by the IASB for the purposes of the unaudited pro forma combined consolidated financial information. See “ Notes to Unaudited Pro Forma Combined Consolidated Financial Information — GAAP to IFRS conversion of APx’s financial information as of June 30, 2024 and for the twelve -month period ended June 30, 2024 and the six -month period ended June 30, 2024.” (ii)Includes the liabilities disclosed by APx under “ Accrued expenses and accounts payable.” (iii)Includes the liabilities disclosed by APx under “ Convertible note payable.” See the accompanying notes to the unaudited pro forma combined consolidated financial information.

102 Notes to Unaudited Pro Forma Combined Consolidated Financial Information Description of Business Combination On March 25, 2024, APx, OmnigenicsAI and Merger Sub entered into the Business Combination Agreement. Subject to the terms and conditions of the Business Combination Agreement, at the Merger Effective Time: •each SPAC Unit issued and outstanding immediately prior to the Merger Effective Time shall be automatically separated and the holder thereof shall be deemed to hold one SPAC Class A Ordinary Share and one -halfof a SPAC Warrant; provided that no